A-listers provide a $50M B round to AstraZeneca’s antibiotics spinout Entasis

John Carroll Last summer, AstraZeneca formally spun out its pared-down early-stage antibiotics unit in Waltham, MA, as Entasis Therapeutics, bequeathing a $ 40 million A round for ...

Melinta grabs $67M in pursuit of a big PhIII antibiotics finish, NDA

John Carroll A few months after raising $ 357 million to back their new biotech investment group, the ex-Elan team at Malin Corp. has helped place a $ 67 million bet on Melinta Therapeutics, ...

Sanofi launches a new antibiotics effort, teams with Fraunhofer

John Carroll Sanofi is joining forces with researchers at Germany's Fraunhofer-Gesellschaft in the hunt for new antibiotics. The pharma giant is setting up a new collaboration that ...

As germs outpace antibiotics, developers hunt for new solutions

Damian Garde The rise of antibiotic-resistant bacteria has become a global scourge, and researchers across academia and industry are taking novel steps to fight back. FierceBiotech ...

Bill would fast-track promising antibiotics for FDA approval

Emily Mullin A group of bipartisan members in the House of Representatives introduced a bill late Thursday that aims to combat the growing threat of so-called "superbugs" ...

Former FDA Commishs To White House: Limit Antibiotics In Livestock

esilverman A pair of former FDA commissioners has written a letter to the White House Office of Management and Budget to urge the Obama administration to end the use of antibiotics ...

CDC director warns antibiotics pipeline ‘nearly empty’

Emily Mullin Antimicrobial resistance is on the rise in the U.S. and elsewhere, and healthcare providers are running out of drugs in their arsenal to combat some pathogens, leaving ...

GlobalData report explores antibiotics market opportunity

mia.burns By Mia Burns (mia.burns@ubm.com)  The rising demand for antibiotics to counter increasing cases of drug-resistant infections, combined with decreasing R&D costs, is ...

Cubist splurges on Trius and Optimer buyouts to spur antibiotics growth

Ryan McBride Cubist Pharmaceuticals surprised some analysts with the announcements of two major acquisitions Tuesday afternoon, agreeing to buy both Trius Therapeutics and Optimer Pharmaceuticals ...

A Senate Bill To Limit Antibiotics In Food-Producing Animals

esilverman In the latest effort to combat the spread of superbugs that are resistant to antibiotics, a bill was introduced in the US Senate that would direct the FDA to prohibit ...

GlaxoSmithKline wins up to $200M federal contract to develop new antibiotics

Emily Mullin In the first collaboration of its kind, the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority has brought on GlaxoSmithKline ...

Achaogen nails $60M in government funding to push antibiotics pipeline

Emily Mullin Antibiotics maker Achaogen announced today that it has landed a $ 60 million contract option from the federal Biomedical Advanced Research and Development Authority (BARDA) ...
Page 1 of 212
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS